Surprisingly, this effect was by no means correlated with TLR3 levels in CCA cells, although TLR3 expression is proposed as a biomarker for the therapeutic efficacy of dsRNA in breast cancer patients [18]. Here, TLR3 is linked to cholangiocarcinoma.